Calciumfolinat Kabi

Calciumfolinat Kabi is a pharmaceutical product containing calcium folinate, used for various medical purposes. This intravenous solution is manufactured by Fresenius Kabi Deutschland Gmbh and is suitable for specific therapeutic needs.

Calciumfolinat Kabi is primarily used to counteract the effects of folic acid antagonists, such as methotrexate, in cases of overdose or toxicity. It is also employed to enhance the effectiveness of certain chemotherapy treatments by modulating folate metabolism. Calcium folinate is often utilized in the management of conditions where folate deficiency is a concern, supporting cellular function and growth.

When administered intravenously, Calciumfolinat Kabi works by providing a source of folinic acid, which plays a crucial role in DNA synthesis and repair. This can help mitigate the side effects of certain medications and support overall cellular health. Users may experience improved outcomes in conditions related to folate deficiency or chemotherapy-induced toxicity.

Calciumfolinat Kabi should be handled with care, ensuring proper sterile techniques during administration to prevent contamination. It is important to follow healthcare provider instructions regarding dosage and administration to avoid potential complications. Patients with known allergies to folinic acid or any components of the solution should exercise caution.

Calciumfolinat Kabi may interact with certain medications, particularly those that affect folate metabolism or are folic acid antagonists. It is advisable to consult with a healthcare provider before combining it with other treatments. Alcohol and certain supplements may also influence its effectiveness, so it is important to discuss all current medications and supplements with a healthcare professional.